Description
Pharmacoeconomics has been used, in various ways, at the institutional level, for formulary decision making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.
This program has received an unrestricted educational grant or in-kind support from Pharmascience.